Amwise Diagnostic Company
Amwise Diagnostic is a leader in precision medicine technology for cancer. Our patented genetic analysis technologies assist doctors and patients in determining the most appropriate individualized treatment strategy that has optimal treatment effectiveness and minimal treatment-related adverse events.
%20.jpg)
%20.jpg)
Funding Status:
Early Stage Venture
Headquarters:
Taipei, T'ai-pei, Taiwan
Founded Date:
2015-01-01
Employee Number:
11-50
Last Funding Type:
Series B
Total Funding:
$10M
Estimated Revenue:
$1M to $10M
Industry:
Biotechnology, Health Care, Life Science
Investors Number:
4
Technology:
diagnostics
Last Funding Date:
2020-02-26